Results 1 to 10 of about 85,138 (220)
Introduction to the PANLAR Guidelines: Giant Cell Arteritis
Global Rheumatology, 2022 Introduction to the PANLAR Guidelines: Giant Cell Arteritis Dr. Sebastián Unizony describes how the process of construction and consolidation of this document by a team of experts was.
Sebastian Unizony
doaj +1 more source
Inflammatory vaginitis in women on long-term rituximab treatment for autoimmune disorders
BMC Women's Health, 2021 Background Consequences of long-term B cell depletion with rituximab are not well understood. We describe inflammatory vaginitis as a potential side effect of long-term rituximab treatment, distinct from previously described vulvovaginal pyoderma ...
Laura Yockey +8 more
doaj +1 more source
Case Reports in Nephrology and Dialysis, 2022 Renal involvement in systemic lupus erythematosus is usually exhibited as lupus nephritis, which is a form of immune complex-mediated glomerulonephritis and one of the most severe organ manifestations of systemic lupus erythematosus.
Chee Eng Chan +3 more
doaj +1 more source
DMW - Deutsche Medizinische Wochenschrift, 2016 Glomerulonephritis encompasses a group of diseases that are characterized by inflammatory glomerular processes and clinically usually present with a nephritic and / or a nephrotic syndrome, as well as a deterioration of the renal function. Often, the diseases are accompanied by arterial hypertension and severe edema. In many cases however, the clinical
Rolf Ak, Stahl, Elion, Hoxha
openaire +2 more sources
Secondary syphilis associated crescentic glomerulonephritis: A case report
Human Pathology Reports, 2021 Introduction: Syphilis is a sexually transmitted disease caused by the bacterium Treponema Pallidum and has a diverse clinical presentation, including nephropathies, the most common of which is membranous nephropathy. Crescentic glomerulonephritis is not
Marcelo Santos Sampaio +5 more
doaj +1 more source
BMC Nephrology, 2020 Background C3 glomerulonephritis is a recently described entity with heterogeneous histopathological features. This study was conducted to assess the effect of reclassification of C3 glomerulopathies on renal outcomes, mortality, and response to therapy.
P. Puri +5 more
doaj +1 more source
Combination Therapy With Rituximab and Cyclophosphamide for Remission Induction in ANCA Vasculitis
Kidney International Reports, 2018 Remission induction in antineutrophil cytoplasmic autoantibody (ANCA) vasculitis may be complicated by slow response to treatment and toxicity from glucocorticoids.
Frank B. Cortazar +6 more
doaj +1 more source
Incidence of glomerulonephritis in the western part of Switzerland over the last decade
Swiss Medical Weekly, 2020 BACKGROUND Glomerulonephritis is a rare yet serious group of diseases with a high risk of progression to end-stage renal disease. For optimal healthcare planning, detailed epidemiological and demographic data are essential.
Giliane Nanchen +6 more
doaj +1 more source
Membranoproliferative glomerulonephritis [PDF]
Pediatric Nephrology, 2009 Membranoproliferative glomerulonephritis is an uncommon kidney disorder characterized by mesangial cell proliferation and structural changes in glomerular capillary walls. It can be subdivided into idiopathic and secondary forms, which are differentially diagnosed by a review of clinical features, laboratory data, and renal histopathology.
Alchi, Bassam, Jayne, David
openaire +3 more sources
Архивъ внутренней медицины, 2020 The review provides up-to-date information on the etiological factors and pathogenic mechanisms of development, morphological changes, clinical and laboratory manifestations of acute glomerulonephritis, as well as therapeutic possibilities for its ...
I. T. Murkamilov +4 more
doaj +1 more source